Skip to content

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

March 6, 2020 / Arfinn Med MD /

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city.

MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and dementia patients.

According to the Alzheimer’s Association, 5.8 million Americans have the disease, a degenerative brain disorder that affects a person’s memory and thinking skills. While there are drugs that help ease symptoms, they do not change the course of the disease.

Albert Gutierrez, CEO of MedPharm, sees Alzheimer’s as “one of the biggest things that’s plaguing our country now and in the future.” That’s why he’s excited about cannabis’ potential to treat it.

Read Full Article Here

Stories you may be interested in

Medical marijuana advocates concerned over recreational cannabis proposals

ALBUQUERQUE, N.M.— Some medical marijuana patients are concerned the proposed framework for legalizing recreational marijuana could have a potentially negative impact on the medical cannabis program. “It’s something that will devastate the medical program in doing so,” said Jason Barker, a medical cannabis advocate with Safe Access New Mexico. A special task force delivered a…
Read More →

European Parliament Passes Cannabis Resolution, Joins WHO In Supporting Medical Marijuana

Following reports about the World Health Organization (WHO) recommending a rescheduling of cannabis and several of its key components under international drug treaties, the European Parliament voted on Wednesday on a resolution that would help advance medical cannabis in the countries that form the European Union. Read the full story here.
Read More →

Americans Are Googling CBD More Than Acupuncture, Meditation And Exercise, Study Finds

People are increasingly more interested in CBD—or cannabidiol—than other health trends such as acupuncture, apple cider vinegar, exercise and veganism, according to a new review. In fact, the non-intoxicating cannabis compound has risen in popularity so much that people Google it nearly as much as they do for yoga and e-cigarettes. In a paper published…
Read More →

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society: “Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast…
Read More →

Medical marijuana users tell their stories to Medical Cannabis Study Commission

Thursday, the Medical Cannabis Study Commission held its third meeting. The Commission has been tasked with presenting a policy recommendation to the legislature on exactly what the best medical marijuana bill should look like. The Commission held a public hearing in which a number of medical marijuana users claimed that the drug has benefitted them.…
Read More →

Aching for a Better Alternative?

To close out Arthritis Awareness Month, we’re highlighting how medical marijuana may be a beneficial alternative treatment for this painful and debilitating disease. With over 31 million Americans suffering from various types of arthritis, the condition stands as the leading disability throughout the U.S. As many may know, arthritis is most common among the middle-aged…
Read More →

Leave a Comment

You must be logged in to post a comment.